The Daily Market Rhapsody: Unpacking Today's Big Swings and Startling Surprises
The CRISPR Conundrum: A Pioneering Gene Therapy Paused by Unexpected Risk
A CRISPR Conundrum: Intellia's Trial Halt Jolts the Biotech World
The CRISPR Horizon: Intellia's Bold Leap Into Our Genetic Future, One Edit at a Time
Biotech's Pulse: Gene-Editing's Leap, Cancer's New Fights, and What's Stirring the Industry
The Shaking Ground: Intellia's Gene-Editing Dream Hits a Harsh Reality Check with Trial Setback
Midday Market Movers: Biotech Rockets, Tech Soars, and a Coffee Giant Stumbles
Cathie Wood's ARK Invest Stacks Up on Alibaba, Baidu, and Biotech Gems in Active Week